Hubei Biocause Pharmaceutical Co (SZSE:000627) ROCE % : 2.87% (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Hubei Biocause Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hubei Biocause Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 2.87%.

Hubei Biocause Pharmaceutical Co ROCE % Historical Data

The historical data trend for Hubei Biocause Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Biocause Pharmaceutical Co ROCE % Chart

Hubei Biocause Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

6.51

1.67

13.20

12.05

8.02

Hubei Biocause Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															17.15	3.85	7.11	3.47	2.87

Hubei Biocause Pharmaceutical Co ROCE % Calculation

Hubei Biocause Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	21709.68	/	( ( (288598.69 - 24985.753)	+	(301935.93 - 24462.097) )	/ 2 )
	=	21709.68	/	( (263612.937	+	277473.833)	/ 2 )
	=	21709.68	/	270543.385
	=	8.02 %

Hubei Biocause Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	7701.836	/	( ( (301935.93 - 24462.097)	+	(282374.342 - 23537.098) )	/ 2 )
	=	7701.836	/	( ( 277473.833	+	258837.244 )	/ 2 )
	=	7701.836	/	268155.5385
	=	2.87 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Hubei Biocause Pharmaceutical Co (SZSE:000627) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hubei Biocause Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Hubei Biocause Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Biocause Pharmaceutical Co (SZSE:000627) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2nd Floor, Building 1, No. 1 Tianshan Road, Guohua Huijin Center, Zhanghe New District, Hubei Province, Jingmen, CHN, 448000

Website

http://www.tianmaogroup.net

Hubei Biocause Pharmaceutical Co Ltd is a China-based company engaged in life insurance, health insurance, accident insurance, and other life insurance businesses, medicine, and chemical businesses. The company generates its revenue in the form of premiums.

Executives

Jiang Hai Hua	Independent director
Fu Yong Jin	Directors, executives
Wu Shi Yan	Supervisors

Hubei Biocause Pharmaceutical Co (SZSE:000627) Headlines

No Headlines